Best AI Index Fund to Buy
Over the last two years, companies with a focus on…
Sell
17
FG Quote, Financials, Valuation and Earnings
Last price:
$31.98
Seasonality move
:
21.66%
Day range:
$31.34 - $32.24
52-week range:
$30.10 - $50.75
Dividend yield:
2.69%
P/E ratio:
8.48x
P/S ratio:
0.86x
P/B ratio:
0.99x
Volume:
217.1K
Avg. volume:
248.7K
1-year change:
-19.25%
Market cap:
$4.3B
Revenue:
$5.4B
EPS (TTM):
$3.77
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $3.4B | $2.2B | $4.3B | $5.4B | |
| Revenue Growth (YoY) | -- | 86.71% | -33.86% | 90.76% | 26.93% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | $129M | $157M | $232M | $296M | |
| Other Inc / (Exp) | -- | -- | -- | -- | $81M | |
| Operating Expenses | -- | $461M | $401M | $885M | $1B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | $29M | $29M | $97M | $132M | |
| EBT. Incl. Unusual Items | -- | $1.6B | $793M | -$35M | $778M | |
| Earnings of Discontinued Ops. | -- | $8M | -- | -- | -- | |
| Income Tax Expense | -- | $320M | $158M | $23M | $136M | |
| Net Income to Company | -- | $1.2B | $635M | -$58M | $642M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -$3M | |
| Net Income to Common Excl Extra Items | -- | $1.2B | $635M | -$58M | $639M | |
| Basic EPS (Cont. Ops) | -- | $11.81 | $5.52 | -$0.47 | $4.98 | |
| Diluted EPS (Cont. Ops) | -- | $11.81 | $5.52 | -$0.47 | $4.88 | |
| Weighted Average Basic Share | -- | $105M | $115M | $124M | $125M | |
| Weighted Average Diluted Share | -- | $105M | $115M | $124M | $131M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -- | $1.6B | $822M | $62M | $910M | |
| Revenue (Reported) | -- | $3.4B | $2.2B | $4.3B | $5.4B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -- | $1.6B | $822M | $62M | $910M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $637M | $812M | $1.5B | $854M | |
| Revenue Growth (YoY) | -- | -- | 27.47% | 86.58% | -43.63% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | $30M | $53M | $66M | $67M | |
| Other Inc / (Exp) | -- | $10M | $23M | $66M | $73M | |
| Operating Expenses | -- | $194M | $238M | $236M | $370M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | $8M | $22M | $30M | $40M | |
| EBT. Incl. Unusual Items | -- | $345M | -$203M | $142M | -$26M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | $106M | -$8M | $26M | -$5M | |
| Net Income to Company | -- | $239M | -$195M | $116M | -$21M | |
| Minority Interest in Earnings | -- | -- | -- | -$1M | -- | |
| Net Income to Common Excl Extra Items | -- | $239M | -$195M | $115M | -$21M | |
| Basic EPS (Cont. Ops) | -- | $12.69 | -$1.56 | $0.90 | -$0.20 | |
| Diluted EPS (Cont. Ops) | -- | $12.69 | -$1.56 | $0.88 | -$0.20 | |
| Weighted Average Basic Share | -- | $18.8M | $125M | $124M | $126M | |
| Weighted Average Diluted Share | -- | $18.8M | $125M | $130M | $126M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -- | $353M | -$181M | $172M | $14M | |
| Revenue (Reported) | -- | $637M | $812M | $1.5B | $854M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -- | $353M | -$181M | $172M | $14M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $2.4B | $5B | $4.8B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | $180M | $245M | $297M | |
| Other Inc / (Exp) | -- | $10M | $51M | $109M | $88M | |
| Operating Expenses | -- | -- | $445M | $883M | $1.2B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | $16M | $43M | $105M | $142M | |
| EBT. Incl. Unusual Items | -- | -- | $245M | $310M | $610M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | $44M | $57M | $105M | |
| Net Income to Company | -- | -- | $201M | $253M | $505M | |
| Minority Interest in Earnings | -- | -- | -- | -$1M | -$2M | |
| Net Income to Common Excl Extra Items | -- | -- | $201M | $252M | $503M | |
| Basic EPS (Cont. Ops) | -- | -- | $27.42 | $2.00 | $3.90 | |
| Diluted EPS (Cont. Ops) | -- | -- | $27.42 | $1.96 | $3.77 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -- | -- | $288M | $415M | $752M | |
| Revenue (Reported) | -- | -- | $2.4B | $5B | $4.8B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -- | -- | $288M | $415M | $752M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $637M | $812M | $1.5B | $854M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | $30M | $53M | $66M | $67M | |
| Other Inc / (Exp) | -- | $10M | $23M | $66M | $73M | |
| Operating Expenses | -- | $194M | $238M | $236M | $370M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | $8M | $22M | $30M | $40M | |
| EBT. Incl. Unusual Items | -- | $345M | -$203M | $142M | -$26M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | $106M | -$8M | $26M | -$5M | |
| Net Income to Company | -- | $239M | -$195M | $116M | -$21M | |
| Minority Interest in Earnings | -- | -- | -- | -$1M | -- | |
| Net Income to Common Excl Extra Items | -- | $239M | -$195M | $115M | -$21M | |
| Basic EPS (Cont. Ops) | -- | $12.69 | -$1.56 | $0.90 | -$0.20 | |
| Diluted EPS (Cont. Ops) | -- | $12.69 | -$1.56 | $0.88 | -$0.20 | |
| Weighted Average Basic Share | -- | $18.8M | $125M | $124M | $126M | |
| Weighted Average Diluted Share | -- | $18.8M | $125M | $130M | $126M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -- | $353M | -$181M | $172M | $14M | |
| Revenue (Reported) | -- | $637M | $812M | $1.5B | $854M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -- | $353M | -$181M | $172M | $14M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $889M | $1.5B | $960M | $1.6B | $2.3B | |
| Short Term Investments | $26B | $30.3B | $32.8B | $41.9B | $26.5B | |
| Accounts Receivable, Net | $3.2B | $3.6B | $5.4B | $9B | $13.4B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $421M | $613M | $941M | $931M | $1.1B | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $31B | $36.3B | $39.4B | $53.2B | $42.9B | |
| Property Plant And Equipment | $19M | $21M | -- | -- | -- | |
| Long-Term Investments | $28.2B | $33.9B | $36.1B | $45.5B | $52.7B | |
| Goodwill | $1.8B | $1.8B | $1.7B | $1.7B | $2.2B | |
| Other Intangibles | $1.9B | $2.2B | $3.4B | $4.2B | $5.6B | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $39.8B | $48.7B | $54.6B | $70.2B | $85B | |
| Accounts Payable | $206M | $220M | $231M | $378M | $207M | |
| Accrued Expenses | $359M | $281M | $559M | $651M | $720M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $572M | $504M | $794M | $1.1B | $1B | |
| Long-Term Debt | $589M | $977M | $1.1B | $1.8B | $2.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $35.7B | $44.2B | $52.2B | $67.1B | $81B | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | $1.2B | $734M | -$2.8B | -$2B | -$1.9B | |
| Common Equity | $4.1B | $4.5B | $2.4B | $3.1B | $4B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | $125M | |
| Total Equity | $4.1B | $4.5B | $2.4B | $3.1B | $4.1B | |
| Total Liabilities and Equity | $39.8B | $48.7B | $54.6B | $70.2B | $85B | |
| Cash and Short Terms | $26.8B | $31.9B | $33.7B | $43.4B | $28.8B | |
| Total Debt | -- | $977M | $1.1B | $1.8B | $2.2B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | $1.6B | $2.4B | $3.3B | |
| Short Term Investments | -- | -- | $35B | $23B | $25.2B | |
| Accounts Receivable, Net | -- | -- | $6.4B | $10.1B | $14.7B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | -- | -- | $43.4B | $36.5B | $44B | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | -- | -- | $38.4B | $46.8B | $52.9B | |
| Goodwill | -- | -- | $1.7B | $2B | $2.2B | |
| Other Intangibles | -- | -- | $3.7B | $4.6B | $5.7B | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | -- | $59.4B | $74.4B | $88B | |
| Accounts Payable | -- | -- | $237M | $250M | $259M | |
| Accrued Expenses | -- | -- | $611M | $630M | $801M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | $851M | $1.4B | $1.2B | |
| Long-Term Debt | -- | -- | $1.6B | $1.4B | $2.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | $56.9B | $70.8B | $83.5B | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | -- | -- | -$2.5B | -$1.9B | -$1.7B | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | $250M | -- | |
| Minority Interest, Total | -- | -- | -- | $137M | $122M | |
| Total Equity | -- | -- | $2.5B | $3.7B | $4.5B | |
| Total Liabilities and Equity | -- | -- | $59.4B | $74.4B | $88B | |
| Cash and Short Terms | -- | -- | $36.6B | $25.4B | $28.5B | |
| Total Debt | -- | -- | $1.6B | $1.7B | $2.2B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | $1.2B | $635M | -$58M | $642M | |
| Depreciation & Amoritzation | -- | $271M | $324M | $412M | $569M | |
| Stock-Based Compensation | -- | $9M | $12M | $23M | $29M | |
| Change in Accounts Receivable | -- | $149M | $148M | $94M | -$19M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | $1.9B | $3.2B | $5.8B | $6B | |
| Capital Expenditures | -- | $33M | $32M | $27M | $24M | |
| Cash Acquisitions | -- | -$1.8B | -$987M | -$1.1B | -$1.6B | |
| Cash From Investing | -- | -$6.9B | -$9.4B | -$8.9B | -$8B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -$101M | -$121M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $550M | $845M | $1.1B | |
| Long-Term Debt Repaid | -- | -- | -- | -$185M | -$615M | |
| Repurchase of Common Stock | -- | -- | -- | -$18M | -$12M | |
| Other Financing Activities | -- | $5.2B | $5.1B | $3.1B | $2.1B | |
| Cash From Financing | -- | $5.6B | $5.6B | $3.7B | $2.7B | |
| Beginning Cash (CF) | -- | $889M | $1.5B | $960M | $1.6B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | $644M | -$573M | $603M | $701M | |
| Ending Cash (CF) | -- | $1.5B | $960M | $1.6B | $2.3B | |
| Levered Free Cash Flow | -- | $1.8B | $3.1B | $5.8B | $6B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | $239M | -$195M | $116M | -$21M | |
| Depreciation & Amoritzation | -- | $76M | $90M | $123M | $153M | |
| Stock-Based Compensation | -- | $3M | $5M | $7M | $8M | |
| Change in Accounts Receivable | -- | $35M | -- | -$22M | -$13M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | $423M | $1.4B | $1.5B | $956M | |
| Capital Expenditures | -- | $11M | $6M | $7M | $5M | |
| Cash Acquisitions | -- | -$290M | -$293M | -$534M | -$664M | |
| Cash From Investing | -- | -$2.2B | -$2.4B | -$1.4B | -$809M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -$25M | -$26M | -$30M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | $375M | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -$300M | |
| Repurchase of Common Stock | -- | -- | -- | -$6M | -$3M | |
| Other Financing Activities | -- | $1.4B | $1.2B | $441M | $571M | |
| Cash From Financing | -- | $1.4B | $1.6B | $659M | $882M | |
| Beginning Cash (CF) | -- | $1.5B | $960M | $1.6B | $2.3B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -$365M | $624M | $809M | $1B | |
| Ending Cash (CF) | -- | $1.2B | $1.6B | $2.4B | $3.3B | |
| Levered Free Cash Flow | -- | $412M | $1.4B | $1.5B | $951M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | $201M | $253M | $505M | |
| Depreciation & Amoritzation | -- | -- | $338M | $445M | $599M | |
| Stock-Based Compensation | -- | $3M | $14M | $25M | $30M | |
| Change in Accounts Receivable | -- | -- | $113M | $72M | -$10M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | $4.2B | $5.9B | $5.4B | |
| Capital Expenditures | -- | $11M | $27M | $28M | $22M | |
| Cash Acquisitions | -- | -$290M | -$990M | -$1.4B | -$1.7B | |
| Cash From Investing | -- | -- | -$9.6B | -$7.9B | -$7.4B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -$25M | -$102M | -$125M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | $845M | $1.4B | |
| Long-Term Debt Repaid | -- | -- | -- | -$185M | -$915M | |
| Repurchase of Common Stock | -- | -- | -- | -$24M | -$9M | |
| Other Financing Activities | -- | -- | $4.8B | $2.4B | $2.2B | |
| Cash From Financing | -- | -- | $5.8B | $2.8B | $2.9B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | $416M | $788M | $921M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | $4.2B | $5.9B | $5.4B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | $239M | -$195M | $116M | -$21M | |
| Depreciation & Amoritzation | -- | $76M | $90M | $123M | $153M | |
| Stock-Based Compensation | -- | $3M | $5M | $7M | $8M | |
| Change in Accounts Receivable | -- | $35M | -- | -$22M | -$13M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | $423M | $1.4B | $1.5B | $956M | |
| Capital Expenditures | -- | $11M | $6M | $7M | $5M | |
| Cash Acquisitions | -- | -$290M | -$293M | -$534M | -$664M | |
| Cash From Investing | -- | -$2.2B | -$2.4B | -$1.4B | -$809M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -$25M | -$26M | -$30M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | $375M | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -$300M | |
| Repurchase of Common Stock | -- | -- | -- | -$6M | -$3M | |
| Other Financing Activities | -- | $1.4B | $1.2B | $441M | $571M | |
| Cash From Financing | -- | $1.4B | $1.6B | $659M | $882M | |
| Beginning Cash (CF) | -- | $1.5B | $960M | $1.6B | $2.3B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -$365M | $624M | $809M | $1B | |
| Ending Cash (CF) | -- | $1.2B | $1.6B | $2.4B | $3.3B | |
| Levered Free Cash Flow | -- | $412M | $1.4B | $1.5B | $951M | |
Get FG Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
FG
Sector
P/E ratio
8.48x
11.67x
PEG ratio
0.09x
0.39x
P/B ratio
0.99x
1.05x
Price / LTM sales
0.86x
2.53x
Growth Metrics
FG
Sector
Revenue growth
-43.63%
5.04%
Earnings growth
49.04%
2.87%
Revenue (5-year growth)
--
5.18%
Earnings forecast
$0.96
$0.56
Profitability
FG
Sector
Profitability FY 2025
--
$138.7M
Return on invested capital
8.18%
5.3%
Return on assets
0.61%
0.97%
Return on equity
12.26%
9.25%
Earnings Date
Last Earnings Date
May
7
Next Earnings Date
Aug
5
Estimated Next Earnings Date
Aug
6
Balance Sheet
FG
Sector
Total cash
$28.5B
$470.2M
Short term investments
$26.5B
$233.7M
Total assets
$85B
$4B
Long term debt
$2.2B
$296.9M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Salesforce Stock Be in 5 Years?
Salesforce (NYSE: CRM) just turned in a quarter that, on…
2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for Jun 2
Regeneron Pharmaceuticals [REGN] is down 0.53% over the past day.
Buy
55
RGC alert for Jun 2
Regencell Bioscience Holdings [RGC] is down 8.78% over the past day.
Sell
42
AMBA alert for Jun 2
Ambarella [AMBA] is down 1.63% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
